COMPARISON OF THE EFFECTS OF E3810 AND OMEPRAZOLE ON DIAZEPAM PHARMACOKINETICS IN EXTENSIVE AND POOR METABOLIZERS OF S-MEPHENYTOIN

被引：0
|
作者：
ISHIZAKI, T
CHIBA, K
MANABE, K
KOYAMA, E
YASUDA, S
HORAI, Y
TOMONO, Y
YAMATO, S
机构：
[1] NTL MED CTR,CLIN RES INST,DIV CLIN PHARMACOL,TOKYO,TOKYO,JAPAN
[2] EISAI & CO LTD,TOKYO,TOKYO,JAPAN
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1994年 / 55卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：141 / 141
页数：1
相关论文
共 28 条
  • [1] COMPARISON OF THE INTERACTION POTENTIAL OF A NEW PROTON PUMP INHIBITOR, E3810, VERSUS OMEPRAZOLE WITH DIAZEPAM IN EXTENSIVE AND POOR METABOLIZERS OF S-MEPHENYTOIN 4'-HYDROXYLATION
    ISHIZAKI, T
    CHIBA, K
    MANABE, K
    KOYAMA, E
    HAYASHI, M
    YASUDA, S
    HORAI, Y
    TOMONO, Y
    YAMATO, C
    TOYOKI, T
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (02) : 155 - 164
  • [2] PHARMACOKINETICS OF E3810 AND OMEPRAZOLE IN RELATION TO POLYMORPHIC HYDROXYLATION OF S-MEPHENYTOIN
    YASUDA, S
    HORAI, Y
    TOMONO, Y
    NAKAI, H
    YAMATO, C
    MANABE, K
    KOBAYASHI, K
    CHIBA, K
    ISHIZAKI, T
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 165 - 165
  • [3] Inhibition of the sulfoxidation of omeprazole by ketoconazole in poor and extensive metabolizers of S-mephenytoin
    Bottiger, Y
    Tybring, G
    Gotharson, E
    Bertilsson, L
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (04) : 384 - 391
  • [4] An S-mephenytoin cysteine conjugate identified in urine of extensive but not of poor metabolizers of S-mephenytoin
    Tyring, G
    Nordin, J
    Bergman, T
    Bertilsson, L
    PHARMACOGENETICS, 1997, 7 (05): : 355 - 360
  • [5] SLOW OMEPRAZOLE METABOLIZERS ARE ALSO POOR S-MEPHENYTOIN HYDROXYLATORS
    ANDERSSON, T
    REGARDH, CG
    DAHLPUUSTINEN, ML
    BERTILSSON, L
    THERAPEUTIC DRUG MONITORING, 1990, 12 (04) : 415 - 416
  • [6] Stereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor, in extensive and poor metabolizers of S-mephenytoin
    Tanaka, M
    Ohkubo, T
    Otani, K
    Suzuki, A
    Kaneko, S
    Sugawara, K
    Ryokawa, Y
    Ishizaki, T
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) : 108 - 113
  • [7] COMPARISON OF THE KINETIC DISPOSITION AND METABOLISM OF E3810, A NEW PROTON PUMP INHIBITOR, AND OMEPRAZOLE IN RELATION TO S-MEPHENYTOIN 4'-HYDROXYLATION STATUS
    YASUDA, S
    HORAI, Y
    TOMONO, Y
    NAKAI, H
    YAMATO, C
    MANABE, K
    KOBAYASHI, K
    CHIBA, K
    ISHIZAKI, T
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (02) : 143 - 154
  • [8] DISPOSITION KINETICS AND METABOLISM OF OMEPRAZOLE IN EXTENSIVE AND POOR METABOLIZERS OF S-MEPHENYTOIN 4'-HYDROXYLATION RECRUITED FROM AN ORIENTAL POPULATION
    SOHN, DR
    KOBAYASHI, K
    CHIBA, K
    LEE, KH
    SHIN, SG
    ISHIZAKI, T
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 262 (03): : 1195 - 1202
  • [9] The effect of omeprazole pretreatment on acetaminophen metabolism in rapid and slow metabolizers of S-mephenytoin
    Sarich, T
    Kalhorn, T
    AlSayegh, F
    Adams, S
    Slattery, J
    Goldstein, J
    Nelson, S
    Wright, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (01) : 21 - 28
  • [10] DIAZEPAM METABOLISM IN NATIVE CHINESE POOR AND EXTENSIVE HYDROXYLATORS OF S-MEPHENYTOIN - INTERETHNIC DIFFERENCES IN COMPARISON WITH WHITE SUBJECTS
    ZHANG, Y
    REVIRIEGO, J
    LOU, YQ
    SJOQVIST, F
    BERTILSSON, L
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (05) : 496 - 502
123